Cargando…
Aromatase Inhibitors
Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestr...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Basel :
Birkhäuser Basel : Imprint: Birkhäuser,
2008.
|
| Edición: | 2nd ed. 2008. |
| Colección: | Milestones in Drug Therapy,
|
| Temas: | |
| Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Background and development of aromatase inhibitors
- Aromatase inhibitors and models for breast cancer
- Clinical pharmacology of aromatase inhibitors
- Clinical studies with exemestane
- Clinical studies with letrozole
- Clinical studies with anastrozole
- The third-generation aromatase inhibitors: a clinical overview
- Lessons from the ArKO mouse
- Possible additional therapeutic uses of aromatase inhibitors.